A purple and pink letter v on a white background.
August 10, 2022

4 Treatments to Complement Your Patient's Weight Loss

Achieving a healthy weight is a great accomplishment. Those patients of yours who have lost excess weight have a lot to look forward to, including a healthier, more active life. However, in many cases dramatic weight loss presents new challenge s that could keep patients from fully enjoying the benefits of their weight loss . Skin laxity, sagging skin, and excess skin are common concerns for those who have shed extra weight and typically affects the abdomen, flanks, upper arms, thighs, and even the lower back. The same areas can often hold onto fatty tissue that even diet and exercise might not  budge. Cellulite is another common concern.     

You can help your patients who have recently transformed their bodies with non-invasive aesthetic treatments to tighten skin and treat those stubborn areas. Here s how to give them the toned, sculpted look they re aiming for without resorting to a surgical procedure.  

Surgical vs. Non-Invasive Options    

For patients who have undergone a dramatic weight transformation, there are both surgical and non-invasive options for resolving sagging skin left after weight loss. However, in many cases, going the surgical route isn t necessary, and non-invasive treatments can contour the body effectively without the associated cost, downtime, and risk.    

Surgical procedures for post-weight loss skin laxity, such as tummy tucks, require significant recovery time, tend to be painful during the healing process, leave a scar, and incur a high cost— which is usually not by covered by insurance as they often count as elective cosmetic procedures.  

In contrast, non-invasive aesthetic treatments powered by Venus Concept s industry-leading medical device technology deliver results with little to no discomfort, no downtime, can be completed over a lunch hour, and are safe for all skin types. For your clients, the benefits are clear.  

Non-Invasive Treatments t o Complement Weight Loss    

Whether your patients want to smoothen leftover cellulite, treat stubborn areas of fatty tissue that diet and exercise won t budge, tighten sagging skin, or have an all-over contouring effect, Venus Concept has a solution for them.    

Skin Tightening & Cellulite Reduction    

Both our Venus Versa and Venus Legacy machines offer skin tightening and cellulite reduction , and also address other common aesthetic concerns that come with weight loss, such as non-surgical circumferential reduction   and wrinkle reduction . Their efficacy in treating these issues comes down to the cutting-edge technology powering the (MP) 2 applicator available with both devices. Favored by clinicians for its ease of use, versatility, and ergonomic design, the applicator combines Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields with advanced VariPulse technology to tighten skin, reduce circumference, and reduce cellulite for a smoother, more contoured appearance.   

Additionally, with Venus Legacy ™,  you can augment your clinic offerings with the popular Trim & Tite™ package, which makes an excellent complementary follow-up to the treatments mentioned above. Trim&Tite is a new and effective skin tightening solution that works to ensure patients see superior clinical results quickly and with no downtime, helping them achieve a toned, sculpted appearance even faster.  

Non-Invasive Lipolysis Reduction  

Even with diet and exercise, stubborn areas like the abdomen and flanks tend to hold onto fatty tissue. With various features to enhance patient comfort, fat reduction treatments from Venus Bliss use non-invasive lipolysis , a process that involves using R adio F requency (RF) energy to gently heat and dissolve hard-to-budge fat cells that tend to accumulate in the thighs, abdomen, and other areas . The device can also address a variety of in-demand body contouring needs including, skin tightening and cellulite reduction. Backed by clinically validated effectiveness, Venus Bliss is a comprehensive solution that allows you to deliver results for your patients with no per-treatment usage fees for you as the provider. Your patients will love seeing their slimmer, sleeker silhouette after just a few sessions, with no downtime.  

Skin Resurfacing    

Common side effects of rapid weight loss include stretch mark s, areas of uneven skin texture, and skin dimpling. Venus Viva MD is a highly customizable tabletop device that delivers exceptional skin resurfacing results with low downtime and is safe for all s hades of skin . Using NanoFractional Radio Frequency (RF) with SmartScan technology, Venus Viva MD is a fractional resurfacing system that allows customized control of ablation and coagulation for enhanced efficacy in resolving mild to severe skin damage , including stretch marks. Designed with patient satisfaction in mind, it s an ideal choice for clinicians who are looking for a flexible, powerful skin resurfacing device with a high return on investment. This is also an excellent option for treating scars, should your patients opt for a surgical procedure to remove excess skin after dramatic weight loss.  

To learn more about our industry-leading technology, reach out to one of our experts today!  

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.